Aandeel INSD INSTADOSE PHARMA CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Instadose Pharma Corp.

Aandelen

INSD

US45783B1035

Beurs gesloten - OTC Markets
Andere beurzen
 21:34:47 29-12-2023 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,000001 USD -.--% Intraday-grafiek van Instadose Pharma Corp. -.--% -.--%
2023 TetraPharma Royalty Corp. heeft TetraPharma (Canada) Ltd. overgenomen van Instadose Pharma Corp. (OTCPK:INSD). CI
2022 Instadose Pharma Corp. Kondigt bestuurswijzigingen aan CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..
An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Instadose Pharma Corp. Announces Board Changes
Instadose Pharma Corp. Announces Resignation of Alex Wylie as Chief Financial Officer
Instadose Pharma Corp. Announces CEO Changes
INSTADOSE PHARMA CORP. : Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K)
INSTADOSE PHARMA CORP. : Financial Statements and Exhibits (form 8-K)
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Instadose Pharma Corp. Reports Earnings Results for the Full Year Ended November 30, 2021
INSTADOSE PHARMA CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Instadose US Announces Management Transition
Instadose US Announces Management Transition
Instadose Pharma Corp. Announces Management Transition
INSTADOSE PHARMA CORP. : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events (form 8-K)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers INSD
  4. Nieuws Instadose Pharma Corp.
  5. Andere talen